Nasdaq-listed Predictive Oncology launches $344M DePIN treasury focused on Aethir
Predictive Oncology (POAI), a biotechnology company specializing in AI-driven cancer research, has announced a $344.4 million digital asset treasury centered on Aethir’s ATH token, marking the first time a Nasdaq-listed company will hold and actively manage tokens from a Decentralized Physical Infra…